---
title: "Vaccine Trials Quick Reference"
---

Endpoint validity in vaccine trials is frequently dependent on
precise timing of vaccination and follow-up visits.

::: {.callout-note title="CRA Considerations"}
CRAs should pay particular attention to visit window compliance,
vaccination timing, and specimen collection timing.
Out-of-window visits may directly affect endpoint validity
and should be documented and escalated appropriately.
:::
